BAYESIAN DECISION PROCEDURES FOR DOSE DETERMINING EXPERIMENTS
- 15 May 1995
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 14 (9), 885-893
- https://doi.org/10.1002/sim.4780140904
Abstract
This paper describes the Bayesian decision procedure and illustrates the methodology through an application to dose determination in early phase clinical trials. The situation considered is quite specific: a fixed number of patients are available, to be treated one at a time, with the choice of dose for any patient requiring knowledge of the responses of all previous patients. A continuous range of possible doses is available. The prior beliefs about the dose–response relationship are of a particular form and the gain from investigation is measured in terms of statistical information gathered. How all of these specifications may be varied is discussed. A comparison with the continual reassessment method is made.Keywords
This publication has 10 references indexed in Scilit:
- Bayesian methods for phase I clinical trialsStatistics in Medicine, 1992
- Methods for dose finding studies in cancer clinical trials: A review and results of a monte carlo studyStatistics in Medicine, 1991
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in CancerBiometrics, 1990
- Sequential Designs in BioassayBiometrics, 1990
- Design and Analysis of Phase I Clinical TrialsBiometrics, 1989
- The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical TrialsJournal of the Royal Statistical Society: Series D (The Statistician), 1983
- A Stochastic Approximation MethodThe Annals of Mathematical Statistics, 1951
- A Method for Obtaining and Analyzing Sensitivity DataJournal of the American Statistical Association, 1948